title: Regulator or regulatory shield? The case for reforming Canada's Patented Medicine Prices Review Board.
authors.affiliation: Family and Community Medicine (Zhang), Women's College Hospital; Medical Affairs and Health System Solutions (Martin), Women's College Hospital; Department of Family and Community Medicine, and Institute of Health Policy, Management and Evaluation (Martin), University of Toronto; Department of Medicine and Institute of Health Policy, Management and Evaluation (Naylor), University of Toronto, Toronto, Ont. henryzhang7@gmail.com.
authors.forename: Rujun
authors.initials: R
authors.lastname: Zhang
authors.affiliation: Family and Community Medicine (Zhang), Women's College Hospital; Medical Affairs and Health System Solutions (Martin), Women's College Hospital; Department of Family and Community Medicine, and Institute of Health Policy, Management and Evaluation (Martin), University of Toronto; Department of Medicine and Institute of Health Policy, Management and Evaluation (Naylor), University of Toronto, Toronto, Ont.
authors.forename: Danielle
authors.initials: D
authors.lastname: Martin
authors.affiliation: Family and Community Medicine (Zhang), Women's College Hospital; Medical Affairs and Health System Solutions (Martin), Women's College Hospital; Department of Family and Community Medicine, and Institute of Health Policy, Management and Evaluation (Martin), University of Toronto; Department of Medicine and Institute of Health Policy, Management and Evaluation (Naylor), University of Toronto, Toronto, Ont.
authors.forename: C David
authors.initials: CD
authors.lastname: Naylor
mesh_terms: D002170:Canada; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D055553:Prescription Drugs / Q000191:economics*; D011907:Rate Setting and Review / Q000331:legislation & jurisprudence*
chemical_list: D055553:Prescription Drugs